Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.24 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMII) posted Total Liabilities of $532.03 million for Q2 2026, up 0.9% from the prior quarter.

Analysis

Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition's Total Liabilities came in at $522.73 million.

  • In prior years, Drugs Made In America Acquisition's Total Liabilities was $254,783 in FY2024.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $527.54 million (Q1 2026), $522.73 million (Q4 2025) and $518.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 113.97 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - 45.42 Mn
3 Brookfield 101.47 Bn -96.66 Bn - 377.39 Bn
4 Blackstone 91.35 Bn 85.56 Bn - 30.05 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 338.97 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 15.60 Bn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 462.18 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 2.19 Bn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 21.81 Bn
10 Drugs Made In America Acquisition 652.29 Mn 651.45 Mn - 532.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 532.03 Mn
Mar 31, 2026 527.54 Mn
Dec 31, 2025 522.73 Mn
Sep 30, 2025 518.29 Mn
Dec 31, 2024 254,783.00
API Access

Drugs Made In America Acquisition Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=DMII&period=max&api_key=YOUR_API_KEY